| Nome |
# |
|
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an Infectious Diseases perspective (Agents targeting lymphoid cells surface antigens [I]: CD19, CD20 and CD52), file e268c4ca-3577-a6b7-e053-3a05fe0adea1
|
152
|
|
De-Escalation and Discontinuation of Empirical Antibiotic Treatment in a Cohort of Allogeneic Hematopoietic Stem Cell Transplantation Recipients during the Pre-Engraftment Period, file e268c4c9-ce2d-a6b7-e053-3a05fe0adea1
|
128
|
|
Fluoroquinolone prophylaxis during neutropenia: what can we expect nowadays?, file e268c4ca-65f3-a6b7-e053-3a05fe0adea1
|
114
|
|
Pre-Engraftment Bloodstream Infections after Allogeneic Hematopoietic Cell Transplantation: Impact of T Cell-Replete Transplantation from a Haploidentical Donor, file e268c4cb-6bac-a6b7-e053-3a05fe0adea1
|
105
|
|
Re: "Comparison of antipseudomonal betalactams for febrile neutropenia empiric therapy: systematic review and network metaanalysis" by Horita et al, file e268c4c9-e1a4-a6b7-e053-3a05fe0adea1
|
89
|
|
Evaluation of mass spectrometry-based detection of panfungal serum disaccharide for diagnosis of invasive fungal infections: Results from a collaborative study involving six European clinical centers, file e268c4c9-a305-a6b7-e053-3a05fe0adea1
|
81
|
|
Impact of antibiotic resistance on outcomes of neutropenic cancer patients with Pseudomonas aeruginosa bacteraemia (IRONIC study): Study protocol of a retrospective multicentre international study, file e268c4ca-65f9-a6b7-e053-3a05fe0adea1
|
78
|
|
Use of colistin in adult patients: a cross-sectional study, file e268c4c9-d54c-a6b7-e053-3a05fe0adea1
|
71
|
|
Bacterial infections in hematopoietic stem cell transplant recipients, file e268c4ca-896b-a6b7-e053-3a05fe0adea1
|
66
|
|
Combined use of serum (1,3)-β-d-glucan and procalcitonin for the early differential diagnosis between candidaemia and bacteraemia in intensive care units, file e268c4ca-2c33-a6b7-e053-3a05fe0adea1
|
59
|
|
ECIL guidelines for treatment of Pneumocystis jirovecii pneumonia in non-HIV-infected haematology patients, file e268c4ca-5f4b-a6b7-e053-3a05fe0adea1
|
30
|
|
Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy, file e268c4cc-c929-a6b7-e053-3a05fe0adea1
|
26
|
|
Candida auris Candidemia in Critically Ill, Colonized Patients: Cumulative Incidence and Risk Factors, file e268c4ce-9d89-a6b7-e053-3a05fe0adea1
|
21
|
|
Reply to: “Antiviral Activity and Safety of Darunavir/Cobicistat for Treatment of COVID-19”, file e268c4cc-8bad-a6b7-e053-3a05fe0adea1
|
11
|
|
Bronchoalveolar lavage fluid characteristics and outcomes of invasively mechanically ventilated patients with COVID-19 pneumonia in Genoa, Italy, file e268c4cd-f66b-a6b7-e053-3a05fe0adea1
|
11
|
|
External validation of unsupervised COVID-19 clinical phenotypes and their prognostic impact, file 8667f211-1d12-4413-996c-d35c93fae18d
|
9
|
|
null, file e268c4cd-7625-a6b7-e053-3a05fe0adea1
|
8
|
|
Validation of an Automated System for the Extraction of a Wide Dataset for Clinical Studies Aimed at Improving the Early Diagnosis of Candidemia, file eb013e88-73cb-4784-ad6c-2d656c026b83
|
8
|
|
Higher mortality and intensive care unit admissions in COVID-19 patients with liver enzyme elevations, file 8304aec2-8fd5-45d6-984d-d259fbfaa197
|
6
|
|
Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study, file e268c4cd-9637-a6b7-e053-3a05fe0adea1
|
6
|
|
Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy, file f2e2c9fe-0015-4107-81ef-fb915010dffd
|
6
|
|
Beta-D-glucan in patients with haematological malignancies, file e9a582eb-ff48-4ae9-827b-b8df7ecd1aa7
|
5
|
|
Impact of a mixed educational and semi-restrictive antimicrobial stewardship project in a large teaching hospital in Northern Italy, file e268c4c8-07fc-a6b7-e053-3a05fe0adea1
|
4
|
|
Risk factors for candidemia after open-heart surgery: results from a multicenter case-control study, file e268c4cd-d6e3-a6b7-e053-3a05fe0adea1
|
4
|
|
The Longest Persistence of Viable SARS-CoV-2 With Recurrence of Viremia and Relapsing Symptomatic COVID-19 in an Immunocompromised Patient-A Case Study, file e268c4ce-94ad-a6b7-e053-3a05fe0adea1
|
4
|
|
Prevalence and prognostic value of cardiac troponin in elderly patients hospitalized for COVID-19, file e268c4cf-0177-a6b7-e053-3a05fe0adea1
|
4
|
|
Pneumocystis jirovecii pneumonia in intensive care units: a multicenter study by ESGCIP and EFISG, file 0140954a-79cd-45a4-887d-01b069b16f3d
|
3
|
|
Mortality in KPC-producing Klebsiella pneumoniae bloodstream infections: a changing landscape, file 8df8a16d-6a08-4aca-b419-c74b9ba70b07
|
3
|
|
The role of televancin in the treatment of MRSA infections in hospital, file 95130eab-189d-4a3f-b5d9-d5af807e6a4b
|
3
|
|
Hepatitis B reactivation in HBsAg-negative/HBcAb-positive allogeneic haematopoietic stem cell transplant recipients: risk factors and outcome., file e268c4c6-b9d7-a6b7-e053-3a05fe0adea1
|
3
|
|
Invasive candidiasis in non-hematological patients., file e268c4c6-c642-a6b7-e053-3a05fe0adea1
|
3
|
|
Comparable survival using a CMV-matched or a mismatched donor for CMV+ patients undergoing T-replete haplo-HSCT with PT-Cy for acute leukemia: a study of behalf of the infectious diseases and acute leukemia working parties of the EBMT, file e268c4ca-4f94-a6b7-e053-3a05fe0adea1
|
3
|
|
Recommendations for screening, monitoring, prevention, prophylaxis and therapy of hepatitis B virus reactivation in patients with haematologic malignancies and patients who underwent haematologic stem cell transplantationâa position paper, file e268c4ca-65f6-a6b7-e053-3a05fe0adea1
|
3
|
|
Tocilizumab and steroid treatment in patients with COVID-19 pneumonia, file e268c4cc-ab5a-a6b7-e053-3a05fe0adea1
|
3
|
|
COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role?, file e268c4cd-0f35-a6b7-e053-3a05fe0adea1
|
3
|
|
Recent advances and future perspectives in the pharmacological treatment of Candida auris infections, file 1fdb3499-d185-4dbc-b899-635980a5a3e3
|
2
|
|
Kidney disease and all-cause mortality in patients with COVID-19 hospitalized in Genoa, Northern Italy, file 289f0df2-993e-441f-8b16-3d0cac2a001d
|
2
|
|
Molecular Epidemiological Investigation of a Nosocomial Cluster of C. auris: Evidence of Recent Emergence in Italy and Ease of Transmission during the COVID-19 Pandemic, file 71147a29-e541-4cad-9112-5e2a1bcd6c46
|
2
|
|
New trends in the management of cytomegalovirus infection after allogeneic hematopoietic cell transplantation: a survey of the Infectious Diseases Working Pary of EBMT, file 9bf9f2ef-0fe7-401a-80e8-5849b6d998cd
|
2
|
|
Initial serum (1,3)-β-d-glucan as a predictor of mortality in proven candidaemia: findings from a retrospective study in two teaching hospitals in Italy and Brazil, file e268c4ca-3796-a6b7-e053-3a05fe0adea1
|
2
|
|
No report on Zika virus infection in EBMT registry: Infectious Diseases Working Party statement, file e268c4ca-65fd-a6b7-e053-3a05fe0adea1
|
2
|
|
Bloodstream infections in neutropenic cancer patients: A practical update, file e268c4ca-6604-a6b7-e053-3a05fe0adea1
|
2
|
|
Lower sensitivity of serum (1,3)-β-D-glucan for the diagnosis of candidaemia due to Candida parapsilosis, file e268c4ca-777f-a6b7-e053-3a05fe0adea1
|
2
|
|
Ocrelizumab does not impair B- and T-cell responses to primary VZV infection in a patient with MS, file e268c4cc-0e82-a6b7-e053-3a05fe0adea1
|
2
|
|
Duration of isolation and precautions in immunocompromised patients with COVID-19, file e268c4cd-6a7f-a6b7-e053-3a05fe0adea1
|
2
|
|
Early administration of bamlanivimab in combination with etesevimab increases the benefits of covid-19 treatment: Real-world experience from the liguria region, file e268c4ce-1cc8-a6b7-e053-3a05fe0adea1
|
2
|
|
CD19, CD20 and CD52, file 38d8b166-33ea-4136-b96f-9a34e38d952c
|
1
|
|
Case report: Sotrovimab, remdesivir and nirmatrelvir/ritonavir combination as salvage treatment option in two immunocompromised patients hospitalized for COVID-19, file 6669ed8d-3dc8-45b3-8b78-8e026fde92fe
|
1
|
|
Vaccinations in patients with multiple sclerosis: a real-world, single-center, experience, file 72868655-7d49-49b0-bb27-18bb3da11ff3
|
1
|
|
Molecular Analysis with16s {rRNA} {PCR}/Sanger Sequencing and Molecular Antibiogram performed on {DNA} extracted from valve improve diagnosis and targeted therapy of Infective Endocarditis: a prospective study, file b6055363-94c3-4903-b7e9-2d3bc0d6f61d
|
1
|
|
Coronavirus disease 2019 vaccination in transplant recipients, file d4e6e906-0d23-439b-9523-57b3d1cc3e78
|
1
|
|
Efficacy, safety and feasibility of treatment of chronic HCV infection with directly acting agents in hematopoietic stem cell transplant recipients – Study of infectious diseases working party of EBMT, file d6616141-b9e4-4e8e-ad87-fe46886a865e
|
1
|
|
European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia., file e268c4c6-b8c7-a6b7-e053-3a05fe0adea1
|
1
|
|
Outbreak of Ralstonia pickettii bacteraemia in patients with haematological malignancies and haematopoietic stem cell transplant recipients, file e268c4c7-1e98-a6b7-e053-3a05fe0adea1
|
1
|
|
Serum sickness (Like Reaction) in a patient treated with alemtuzumab for multiple sclerosis: A case report, file e268c4c9-6930-a6b7-e053-3a05fe0adea1
|
1
|
|
Recent advances in the pharmacological management of infections due to multidrug-resistant Gram-negative bacteria, file e268c4c9-acdb-a6b7-e053-3a05fe0adea1
|
1
|
|
Performance of serum (1,3)-ß-d-glucan screening for the diagnosis of invasive aspergillosis in neutropenic patients with haematological malignancies, file e268c4c9-acdf-a6b7-e053-3a05fe0adea1
|
1
|
|
Visceral leishmaniasis in hematopoietic cell transplantation: Case report and review of the literature, file e268c4c9-c8b1-a6b7-e053-3a05fe0adea1
|
1
|
|
Efficacy of lamivudine prophylaxis in preventing hepatitis B virus reactivation in patients with resolved infection undergoing allogeneic SCT and receiving rituximab, file e268c4c9-d017-a6b7-e053-3a05fe0adea1
|
1
|
|
Diagnostic and therapeutic approach to infectious diseases in solid organ transplant recipients, file e268c4c9-d550-a6b7-e053-3a05fe0adea1
|
1
|
|
ECIL guidelines for the prevention, diagnosis and treatment of BK polyomavirus-associated haemorrhagic cystitis in haematopoietic stem cell transplant recipients, file e268c4c9-da1c-a6b7-e053-3a05fe0adea1
|
1
|
|
Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelines, file e268c4c9-e19c-a6b7-e053-3a05fe0adea1
|
1
|
|
Management of chronic viral hepatitis in the hematological patient, file e268c4c9-e1a1-a6b7-e053-3a05fe0adea1
|
1
|
|
Use of 1,3-β-D-glucan in invasive fungal diseases in hematology patients, file e268c4c9-f679-a6b7-e053-3a05fe0adea1
|
1
|
|
Correction to: Impact of a mixed educational and semi-restrictive antimicrobial stewardship project in a large teaching hospital in Northern Italy (Infection, 10.1007/s15010-017-1063-7), file e268c4c9-f85c-a6b7-e053-3a05fe0adea1
|
1
|
|
Management of adenovirus infection in patients after haematopoietic stem cell transplantation: State-of-the-art and real-life current approach: A position statement on behalf of the Infectious Diseases Working Party of the European Society of Blood and Marrow Transplantation, file e268c4ca-355f-a6b7-e053-3a05fe0adea1
|
1
|
|
The prognostic impact of the cytomegalovirus serostatus in patients with chronic hematological malignancies after allogeneic hematopoietic stem cell transplantation: a report from the Infectious Diseases Working Party of EBMT, file e268c4ca-373c-a6b7-e053-3a05fe0adea1
|
1
|
|
Vaccination of patients with haematological malignancies who did not have transplantations: guidelines from the 2017 European Conference on Infections in Leukaemia (ECIL 7), file e268c4ca-373f-a6b7-e053-3a05fe0adea1
|
1
|
|
Non-cultural methods for the diagnosis of invasive fungal disease, file e268c4ca-48c2-a6b7-e053-3a05fe0adea1
|
1
|
|
Vaccination of haemopoietic stem cell transplant recipients: guidelines of the 2017 European Conference on Infections in Leukaemia (ECIL 7), file e268c4ca-65fa-a6b7-e053-3a05fe0adea1
|
1
|
|
Protective environment for hematopoietic cell transplant (HSCT) recipients: The Infectious Diseases Working Party EBMT analysis of global recommendations on health-care facilities, file e268c4ca-65fb-a6b7-e053-3a05fe0adea1
|
1
|
|
Multidrug-resistant bacteria in hematology patients: Emerging threats, file e268c4ca-6600-a6b7-e053-3a05fe0adea1
|
1
|
|
2017 ECIL 7 vaccine guidelines, file e268c4ca-6b07-a6b7-e053-3a05fe0adea1
|
1
|
|
Discontinuation of empirical antibiotic therapy in neutropenic leukaemia patients with fever of unknown origin is ethical, file e268c4ca-87c9-a6b7-e053-3a05fe0adea1
|
1
|
|
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Agents targeting lymphoid or myeloid cells surface antigens [II]: CD22, CD30, CD33, CD38, CD40, SLAMF-7 and CCR4), file e268c4ca-8961-a6b7-e053-3a05fe0adea1
|
1
|
|
Desirability of outcome ranking (DOOR) for comparing diagnostic tools and early therapeutic choices in patients with suspected candidemia, file e268c4ca-898d-a6b7-e053-3a05fe0adea1
|
1
|
|
Efficacy of daptomycin lock therapy in the treatment of bloodstream infections related to long-term catheter., file e268c4ca-8999-a6b7-e053-3a05fe0adea1
|
1
|
|
European survey on principles of prudent antibiotic prescribing teaching in undergraduate students, file e268c4ca-e223-a6b7-e053-3a05fe0adea1
|
1
|
|
Invasive pulmonary aspergillosis in intensive care units: is it a real problem?, file e268c4cb-57d1-a6b7-e053-3a05fe0adea1
|
1
|
|
Extensive activation, tissue trafficking, turnover and functional impairment of NK cells in COVID-19 patients at disease onset associates with subsequent disease severity, file e268c4cd-c3e1-a6b7-e053-3a05fe0adea1
|
1
|
|
Prospective study on incidence, risk factors and outcome of recurrent clostridioides difficile infections, file e268c4ce-93e0-a6b7-e053-3a05fe0adea1
|
1
|
|
8th European Conference on Infections in Leukaemia: 2020 guidelines for the use of antibiotics in paediatric patients with cancer or post-haematopoietic cell transplantation, file ecda4886-1d5e-40d2-958a-240b7f8fa47e
|
1
|
| Totale |
1.191 |